Grit­stone’s top-of-the-range IPO brings week’s biotech Nas­daq tal­ly to $520M

Grit­stone On­col­o­gy joined the fes­tiv­i­ties on Nas­daq overnight, reap­ing a $100 mil­lion wind­fall af­ter up­siz­ing its batch of shares and pric­ing its IPO on the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER